Related Experiment Video
Updated: Nov 2, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
1,3,4-Oxadiazoles as Potential Pharmacophore for Cytotoxic Potentiality: A Comprehensive Review
Divya Sharma1, Salahuddin1, Vikas Sharma1
1Department of Pharmaceutical Chemistry, Noida Institute of Engineering and Technology (Pharmacy Institute), Plot No. 19, KP-2, Greater Noida, Uttar Pradesh-201306, India.
Abstract:
Cancer is a kind of human cell degenerative disease that has affected many people for several years. Cancer is caused due to the abnormal growth of cells in every particular part of the body. The 1,3,4-oxadiazole ring is found to be a binding moiety that has anticancer potential. Various works on the 1,3,4-oxadiazole moiety showing anticancer activity have been reported. The present analysis summarizes general synthetic methods for 1,3,4 oxadiazole. Different receptors on which these drug acts are discussed. This review also presents pharmacophore models for topoisomerase-I, histone deacetylase, and epidermal growth factor enzymes.
Insights
The 1,3,4-oxadiazole ring shows significant anticancer potential. This review summarizes its synthesis, mechanisms of action, and pharmacophore models for key cancer-related enzymes.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- Cancer, characterized by abnormal cell growth, remains a major global health concern.
- The 1,3,4-oxadiazole heterocyclic system has emerged as a promising scaffold in anticancer drug discovery.
- Previous research indicates the 1,3,4-oxadiazole moiety possesses inherent anticancer properties.
Purpose of the Study:
- To review general synthetic methodologies for 1,3,4-oxadiazole derivatives.
- To discuss the various biological targets and receptors that interact with these compounds.
- To present pharmacophore models for crucial enzymes implicated in cancer progression.
Main Methods:
- Literature review of synthetic routes for 1,3,4-oxadiazole compounds.
- Analysis of reported biological activities and target interactions.
- Development and presentation of pharmacophore models for specific enzymes.
Main Results:
- General synthetic strategies for constructing the 1,3,4-oxadiazole core are outlined.
- The review details diverse biological targets, including topoisomerase-I, histone deacetylase, and epidermal growth factor enzymes.
- Pharmacophore models provide insights into structure-activity relationships for anticancer drug design.
Conclusions:
- 1,3,4-oxadiazole derivatives represent a valuable class of compounds with demonstrated anticancer activity.
- Understanding synthetic pathways and target interactions facilitates the rational design of novel anticancer agents.
- Pharmacophore modeling aids in identifying key structural features for enhanced efficacy against cancer targets.

